Pharma Focus Europe

Pharma Focus Europe Welcome to Pharmafocus Europe! Stay updated with the latest in European pharmaceuticals, innovations, and industry news. Ltd..

Join our community for insights and discussions on advancing healthcare. https://www.linkedin.com/company/pharmafocuseurope/ About Pharma Focus Europe:
Pharma Focus Europe is a half yearly publication from Ochre Media Pvt. It is the leading pharma title in print and digital versions serving the information needs of key executives from the world’s leading pharmaceutical companies. Pharma Focus Europe covers important issues and trends shaping the future of the pharma industry across Europe and rest of the world. Pharma Focus Europe offers . . .
• Dedicated, reliable and accurate coverage of the industry’s progress and
• Incisive analysis to help its readers make informed decisions to stay ahead of the competition. The magazine provides cutting-edge and futuristic content on the pharma industry. The issues are broadly categorized into various sections:
• Strategy
• Research and Development
• Manufacturing
• Clinical Trials
• Information Technology

The one-stop pharma destination www.pharmafocuseurope.com features complete content from the Pharma Focus Europe magazine. Also find the latest pharma news, press releases, pharma industry reports, interviews, trends and pharma events updated on a daily basis. The magazine is supplemented by the monthly e-Newsletter: Verticaltalk Pharma. The readership
The magazine’s readership includes the top C-level executives, senior industry executives, and key decision makers from the pharma industry in charge of spending. With a special focus on Europe, Pharma Focus Europe reaches out to the key industry leaders across Europe, Asia and the Americas.

Bringing a new drug to market has never been simple—and it’s only getting more complex.That’s where Agentic AI comes in....
07/04/2026

Bringing a new drug to market has never been simple—and it’s only getting more complex.

That’s where Agentic AI comes in.

In Pharma Focus Europe Issue 07, Raghuraman Sridharan from Cognizant explains how this next wave of AI goes beyond insights to actually take action—helping pharma teams save time, reduce bottlenecks, and make better decisions across R&D.

Whether it’s improving clinical trials or making sense of scattered data, Agentic AI is helping teams focus less on process—and more on patients.

💡 Want to see how this shift is unfolding?

Read the full article: https://www.pharmafocuseurope.com/manufacturing/agentic-ai-the-next-leap-in-drug-discovery

Download the latest ebook here: https://www.pharmafocuseurope.com/magazine

Bringing nanomedicines from the lab to patients isn’t easy—but it’s where real impact happens.In 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐄𝐮𝐫𝐨𝐩𝐞 𝐈𝐬𝐬...
06/04/2026

Bringing nanomedicines from the lab to patients isn’t easy—but it’s where real impact happens.

In 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐄𝐮𝐫𝐨𝐩𝐞 𝐈𝐬𝐬𝐮𝐞 𝟎𝟕, Mark van Eldijk from Ardena explains how flow manufacturing improves consistency, quality, and scalability in nanoparticle production, making the journey from the lab to patients smoother.

It’s not just about better processes—it’s about getting advanced therapies to people who need them, faster.

Read more: https://www.pharmafocuseurope.com/manufacturing/translating-nanomedicine-potential-into-a-scalable

Download the latest eBook from our website today: https://www.pharmafocuseurope.com/magazine

Advanced therapies like mRNA, biologics, and nanoparticle-based medicines are reshaping healthcare—but stability challen...
02/04/2026

Advanced therapies like mRNA, biologics, and nanoparticle-based medicines are reshaping healthcare—but stability challenges remain a major roadblock.

Lyophilisation is proving to be a game-changer by improving shelf life, maintaining product integrity, and reducing reliance on costly cold-chain logistics.

In Pharma Focus Europe Issue 07, Uwe Hanenberg, Head of Product Development (Oral Solid Dose) at Recipharm, breaks down how this technology supports complex therapeutics and addresses formulation, scale-up, and regulatory challenges.

Want to stay updated with the latest in pharma innovation?

Read the full article here: https://www.pharmafocuseurope.com/manufacturing/lyophilisation-key-to-overcoming-stability

Download the newest eBook today: https://www.pharmafocuseurope.com/magazine

Behind every successful clinical trial is a team working hard to keep things moving.But what if shaving off just a few d...
01/04/2026

Behind every successful clinical trial is a team working hard to keep things moving.

But what if shaving off just a few days could make a huge difference?

In Pharma Focus Europe Issue 07, Melissa Hutchens and Gar Crowell from WCG highlight how reducing site activation timelines by even 3 days can cut months off an entire study.

That’s not just efficiency—it’s getting treatments to patients sooner.

From choosing the right sites to speeding up contracts and using smarter data, this article shares practical ways to overcome common delays.

Because in clinical research, every day really does count.

Read the full article:
https://www.pharmafocuseurope.com/clinical-trials/optimising-clinical-trial-start-up

Download the latest eBook now: https://www.pharmafocuseurope.com/magazine

Clinical trial data is the backbone of medical progress—but how do we ensure it remains secure, transparent, and tamper-...
31/03/2026

Clinical trial data is the backbone of medical progress—but how do we ensure it remains secure, transparent, and tamper-proof?

In 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐄𝐮𝐫𝐨𝐩𝐞 – 𝐈𝐬𝐬𝐮𝐞 𝟎𝟕, Debasish Kar, Senior Clinical Project Coordinator at Thermo Fisher Scientific, highlights how blockchain technology is transforming clinical research by improving data integrity, safeguarding patient information, and enhancing trust across stakeholders.

From immutable records to secure data sharing and smarter compliance, blockchain is shaping the future of clinical trials.

Want to stay updated on the latest in pharma innovation?

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐞𝐁𝐨𝐨𝐤 𝐧𝐨𝐰 𝐟𝐫𝐨𝐦 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐚𝐧𝐝 𝐝𝐢𝐯𝐞 𝐢𝐧𝐭𝐨 𝐞𝐱𝐩𝐞𝐫𝐭 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.pharmafocuseurope.com/magazine

𝐇𝐞𝐚𝐝 𝐭𝐨 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐭𝐨 𝐠𝐞𝐭 𝐲𝐨𝐮𝐫 𝐜𝐨𝐩𝐲 𝐭𝐨𝐝𝐚𝐲: https://www.pharmafocuseurope.com/clinical-trials/blockchain-in-securing-clinical-trial-data

𝐈𝐧-𝐯𝐢𝐯𝐨 𝐂𝐀𝐑-𝐓 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 is emerging as a powerful evolution in cell therapy—eliminating complex manufacturing steps and en...
30/03/2026

𝐈𝐧-𝐯𝐢𝐯𝐨 𝐂𝐀𝐑-𝐓 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 is emerging as a powerful evolution in cell therapy—eliminating complex manufacturing steps and enabling immune cells to be engineered directly in the body.

In 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐄𝐮𝐫𝐨𝐩𝐞—𝐈𝐬𝐬𝐮𝐞 𝟎𝟕, Peter Robinson, MBA, Director of Therapeutic Strategy at Novotech, shares a compelling perspective on the science, clinical progress, and regulatory strategies driving this transformation.

From improving patient access to accelerating treatment timelines, the promise of in-vivo CAR-T is clear—but success will depend on precision, safety, and scalability.

𝐆𝐞𝐭 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐬𝐭𝐨𝐫𝐲 𝐚𝐧𝐝 𝐝𝐞𝐞𝐩𝐞𝐫 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧𝐭𝐨 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬:
https://www.pharmafocuseurope.com/research-development/in-vivo-car-t-from-concept-to-clinic

👉 𝐇𝐞𝐚𝐝 𝐭𝐨 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐚𝐧𝐝 𝐝𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐞𝐁𝐨𝐨𝐤 𝐭𝐨𝐝𝐚𝐲: https://www.pharmafocuseurope.com/magazine

In pharma, there’s no room for error.A single temperature excursion or compliance gap can affect product quality—and ult...
27/03/2026

In pharma, there’s no room for error.

A single temperature excursion or compliance gap can affect product quality—and ultimately, patient care. That’s why companies are prioritizing smarter, safer, and more transparent supply chains.

𝐃𝐒𝐕’𝐬 𝐀𝐢𝐫 𝐓𝐡𝐞𝐫𝐦𝐨𝐃𝐢𝐫𝐞𝐜𝐭 is designed for critical, temperature-sensitive shipments—helping reduce risk at every step.
🌡️ Stable temperatures with passive cooling
✈️ Faster handling with direct tarmac access
📊 Real-time monitoring & full visibility
✅ GxP compliance end-to-end

Stronger supply chains mean safer outcomes for patients everywhere.

👉 𝐋𝐞𝐚𝐫𝐧 𝐡𝐨𝐰 𝐰𝐞 𝐜𝐚𝐧 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐲𝐨𝐮𝐫 𝐩𝐡𝐚𝐫𝐦𝐚 𝐥𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐧𝐞𝐞𝐝𝐬—𝐬𝐢𝐠𝐧 𝐮𝐩 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬: https://industry.pharmafocuseurope.com/clientemailblast/1774509169-DSV.html

Malaria remains one of the world’s deadliest infectious diseases, with resistance to existing drugs threatening decades ...
27/03/2026

Malaria remains one of the world’s deadliest infectious diseases, with resistance to existing drugs threatening decades of progress. 𝐃𝐫 𝐕𝐢𝐤𝐫𝐚𝐦 𝐕𝐞𝐧𝐤𝐚𝐭𝐞𝐬𝐰𝐚𝐫𝐚𝐧, 𝐅𝐨𝐮𝐧𝐝𝐞𝐫 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐢𝐚, introduces Trapicolast—an AI-designed, first-in-class antimalarial that targets two essential parasite pathways while minimizing the risk of resistance.

This breakthrough could redefine drug development for neglected diseases and secure the future of malaria control.

𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐡𝐨𝐰 𝐀𝐈 𝐢𝐬 𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐧𝐞𝐱𝐭-𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬:
https://www.pharmafocuseurope.com/articles/trapicolast-drug-resistance-solution

Pharma companies are rethinking stability studies—and for good reason.In 𝐈𝐬𝐬𝐮𝐞 𝟎𝟕 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐄𝐮𝐫𝐨𝐩𝐞, Sneha Chauhan ...
26/03/2026

Pharma companies are rethinking stability studies—and for good reason.

In 𝐈𝐬𝐬𝐮𝐞 𝟎𝟕 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐄𝐮𝐫𝐨𝐩𝐞, Sneha Chauhan (Senior Product Development Specialist, Multisorb Filtration Group) shares how moving from a reactive approach to a proactive, science-driven stability strategy can dramatically reduce risks, prevent costly recalls, and improve product quality.

From managing moisture and oxygen exposure to leveraging 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐛𝐲 𝐃𝐞𝐬𝐢𝐠𝐧 (𝐐𝐛𝐃), this shift is helping manufacturers build quality into products right from the start—not test it at the end.

📉 Lower costs
⚡ Faster timelines
🛡️ Stronger compliance

Take the next step toward smarter pharmaceutical development.
https://www.pharmafocuseurope.com/strategy/from-reactive-to-proactive

👉 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐞𝐁𝐨𝐨𝐤 𝐨𝐧 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐭𝐨𝐝𝐚𝐲:
https://www.pharmafocuseurope.com/magazine

The future of mRNA is evolving fast—and so are the expectations around process development and CMC.Be part of the conver...
25/03/2026

The future of mRNA is evolving fast—and so are the expectations around process development and CMC.

Be part of the conversation at the 𝟒𝐭𝐡 𝐦𝐑𝐍𝐀 𝐏𝐫𝐨𝐜𝐞𝐬𝐬 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 & 𝐂𝐌𝐂 𝐒𝐮𝐦𝐦𝐢𝐭 𝐄𝐮𝐫𝐨𝐩𝐞 in Frankfurt (May 19–21). Connect with top experts from leading pharma companies and regulatory bodies shaping the next generation of mRNA therapies.

✨ 𝐖𝐡𝐚𝐭’𝐬 𝐧𝐞𝐰 𝐭𝐡𝐢𝐬 𝐲𝐞𝐚𝐫:
• AI & automation in real-world mRNA development
• Interactive session: build and test your own mRNA AI system
• Direct insights from European regulators
• Deep dive into analytical development and QC
• Focus on emerging modalities like gene editing & CAR-T

🎟️ Save up to €600 with early bird rates—deadline: March 27!

👉 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐭𝐨𝐝𝐚𝐲: https://industry.pharmafocuseurope.com/clientemailblast/1774355586-mRNA-Process-Development-&-CMC-Summit.html

Digital transformation is changing the way pharmaceutical quality works—bringing speed, automation, and intelligence int...
24/03/2026

Digital transformation is changing the way pharmaceutical quality works—bringing speed, automation, and intelligence into every process.

In 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐄𝐮𝐫𝐨𝐩𝐞—𝐈𝐬𝐬𝐮𝐞 𝟎𝟕, 𝐃𝐫. 𝐒𝐨𝐩𝐡𝐢𝐞 𝐅𝐫ö𝐡𝐥𝐢𝐜𝐡 (𝐓𝐚𝐤𝐞𝐝𝐚) shares how AI, data, and automation are reshaping quality systems—but also introducing new layers of ambiguity.

From electronic batch records to predictive analytics, the shift is powerful—but not simple. Questions around trust, compliance, and human roles are becoming more important than ever.

💡 𝐊𝐞𝐲 𝐭𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:
✔ AI is enhancing—not replacing—human expertise
✔ Regulatory expectations are evolving globally
✔ Digital systems demand new skills and mindsets
✔ Ambiguity is part of transformation—not a barrier

This is more than innovation—it’s a redefinition of how pharma ensures quality and patient safety.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐞𝐛𝐨𝐨𝐤: https://www.pharmafocuseurope.com/magazine

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐧𝐨𝐰:
https://www.pharmafocuseurope.com/strategy/algorithms-audits-and-ambiguity

𝐀𝐠𝐠𝐫𝐞𝐠𝐚𝐭𝐢𝐨𝐧 𝐢𝐬𝐬𝐮𝐞𝐬 𝐢𝐦𝐩𝐚𝐜𝐭𝐢𝐧𝐠 𝐲𝐨𝐮𝐫 𝐦𝐀𝐛 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧?This webinar focuses on practical strategies to help you reduce aggrega...
23/03/2026

𝐀𝐠𝐠𝐫𝐞𝐠𝐚𝐭𝐢𝐨𝐧 𝐢𝐬𝐬𝐮𝐞𝐬 𝐢𝐦𝐩𝐚𝐜𝐭𝐢𝐧𝐠 𝐲𝐨𝐮𝐫 𝐦𝐀𝐛 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧?

This webinar focuses on practical strategies to help you reduce aggregation and improve yield across your downstream process.

From capture to polishing and high-concentration formulation, get insights you can apply immediately.

🧪 𝐓𝐨𝐩𝐢𝐜𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:
✔️ Preventing aggregation during capture
✔️ Effective removal during polishing
✔️ Optimizing TFF and diafiltration steps

📅 March 24
⏰ 09:00 AM CET | 17:00 CET

Learn directly from Cytiva experts Tina Pitarresi and Sandeep Kristiansson.

𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰 𝐚𝐧𝐝 𝐭𝐚𝐤𝐞 𝐜𝐨𝐧𝐭𝐫𝐨𝐥 𝐨𝐟 𝐲𝐨𝐮𝐫 𝐝𝐨𝐰𝐧𝐬𝐭𝐫𝐞𝐚𝐦 𝐩𝐫𝐨𝐜𝐞𝐬𝐬.
https://industry.pharmafocuseurope.com/clientemailblast/1773033322-Cytiva.html

Address

111, 112 First Floor, Block 2, White House
Hyderabad
500016

Website

Alerts

Be the first to know and let us send you an email when Pharma Focus Europe posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category